Suppressors of cytokine signaling regulate angiotensin II-activated janus kinase-signal transducers and activators of transcription pathway in renal cells

被引:41
作者
Hernández-Vargas, P
López-Franco, O
Sanjuán, G
Rupérez, M
Ortiz-Muñoz, G
Suzuki, Y
Aguado-Roncero, P
Pérez-Tejerizo, G
Blanco, J
Egido, J
Ruiz-Ortega, M
Gómez-Guerrero, C
机构
[1] Univ Autonoma Madrid, Renal & Vasc Res Lab, Fdn Jimenez Diaz, E-28040 Madrid, Spain
[2] Univ Autonoma Madrid, Dept Pediat Surg, Fdn Jimenez Diaz, E-28040 Madrid, Spain
[3] Juntendo Univ, Dept Internal Med, Div Nephrol, Tokyo 113, Japan
[4] Hosp Clin San Carlos, Dept Pathol, Madrid, Spain
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 06期
关键词
D O I
10.1681/ASN.2004050374
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Suppressors of cytokine signaling (SOCS) family is constituted by cytokine-inducible proteins that modulate receptor signal transduction via tyrosine kinases, mainly the Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway. Differential SOCS expression was noted in renal cells that were incubated with inflammatory stimuli, but the role of SOCS in the pathogenesis of renal diseases is not yet well defined. Because angiotensin II (Ang II) plays a key role in renal disease, SOCS proteins were studied as a novel mechanism involved in the negative regulation of Ang II-mediated processes. Systemic Ang II infusion for 3 d increased the renal mRNA expression of SOCS-3 and SOCS-1. SOCS protein synthesis was found in glomerular mesangial area and tubules. In cultured mesangial cells and tubular epithelial cells, Ang II induced a rapid and transient SOCS-3 and SOCS-1 expression in parallel with JAK2 and STAT1 activation. In both cell types, overexpression of SOCS proteins prevented the STAT activation in response to Ang II. SOCS expression observed in Ang II-infused rats and in Ang II-stimulated cells was significantly inhibited by treatment with AT(1) but not AT(2) receptor antagonist and was attenuated in mesangial cells from AT(1a)-deficient mice, demonstrating the implication of AT(1) in those responses. In SOCS-3 knockdown studies, antisense oligonucleotides inhibited the expression of SOCS-3 and increased the Ang II-induced STAT activation and c-Fos/c-Jun expression, then resulting in a more severe renal damage. These results suggest that SOCS proteins may act as negative regulators of Ang II signaling in renal cells and implicate SOCS as important modulators of renal damage.
引用
收藏
页码:1673 / 1683
页数:11
相关论文
共 47 条
[41]   A family of cytokine-inducible inhibitors of signalling [J].
Starr, R ;
Willson, TA ;
Viney, EM ;
Murray, LJL ;
Rayner, JR ;
Jenkins, BJ ;
Gonda, TJ ;
Alexander, WS ;
Metcalf, D ;
Nicola, NA ;
Hilton, DJ .
NATURE, 1997, 387 (6636) :917-921
[42]   Inflammation and angiotensin II [J].
Suzuki, Y ;
Ruiz-Ortega, M ;
Lorenzo, O ;
Ruperez, M ;
Esteban, V ;
Egido, J .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (06) :881-900
[43]   Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system:: The role of NF-AT pathway [J].
Suzuki, Y ;
Gómez-Guerrero, C ;
Shirato, I ;
López-Franco, O ;
Hernández-Vargas, P ;
Sanjuán, G ;
Ruiz-Ortega, M ;
Sugaya, T ;
Okumura, K ;
Tomino, Y ;
Ra, C ;
Egido, J .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4136-4146
[44]   Recent advances in angiotensin II signaling [J].
Toyz, RM ;
Berry, C .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2002, 35 (09) :1001-1015
[45]   Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors [J].
Wolf, G ;
Wenzel, U ;
Burns, KD ;
Harris, RC ;
Stahl, RAK ;
Thaiss, F .
KIDNEY INTERNATIONAL, 2002, 61 (06) :1986-1995
[46]   ANGIOTENSIN-II INDUCES CELLULAR HYPERTROPHY IN CULTURED MURINE PROXIMAL TUBULAR CELLS [J].
WOLF, G ;
NEILSON, EG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (05) :F768-F777
[47]   Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways [J].
Yasukawa, H ;
Hoshijima, M ;
Gu, YS ;
Nakamura, T ;
Pradervand, S ;
Hanada, T ;
Hanakawa, Y ;
Yoshimura, A ;
Ross, J ;
Chien, KR .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (10) :1459-1467